Niedrobnokomórkowy rak płuca: badanie fazy III leku sacituzumab tirumotecan i paclitaxel
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC)…